With a wide choice of health supplements in the market today, we should consider some of the following points before making a purchase, especially when it involves our most valuable asset – our health.

• The health product should be natural, proven to be safe for human consumption, free of side effects and supplement nutritional needs
  
  
• It should be backed by a credible theory or hypothesis, i.e., there should be a clear reason why it could work and how it possibly works.
  
  
• It should show benefit from a historical supportive tradition. In other words, there should be a long history of human use and a widespread recognition of the value of the ingredients.
  
  
• It should be the subject of a number of clinical studies on humans and show objective evidence of its safety and efficacy with experienced practitioners in the field. The scientific references should be valid.
  
  SWISSOATS A111® is one such supplement that meets the above criteria. This section will highlight its efficacy and safety while presenting various clinical studies performed.

• SWISSOATS A111® has been tested to contain NO harmful and toxic substances by the Institute of Science and Forensic Medicine in Singapore.
  
  
• It has been awarded US patent certificate no. 4,886,665.
  
  
• It has been clinically tested in Europe, USA and Singapore and has been proven to be both safe and clinically effective.
  
  
• No side effect has been reported since the product was first sold in the US in 1985.
  
  
• It has no known negative interactions with other medications during its 20 over years of use throughout the world as confirmed by the manufacturer from Switzerland.
  
  
• Oats have the distinction of being the holder of the first food-specific health claim ever approved by the United States Food and Drug Administration (FDA). The claim was approved in 1997, and reads, “Soluble fibre from oats, as part of a low saturated fat, low cholesterol diet, may reduce the risk of heart disease.
  

The effectiveness of SWISSOATS A111® and its ingredients has been clinically tested in Europe, USA and Singapore and has been proven to be both safe and effective.

A 6-week double-blind cross-over clinical trial was performed with men averaging 40 years of age in which the effect of SWISSOATS A111® on the static strength of 13 muscle groups was tested. Those receiving placebo did not experience significant change, while improvement was evident in 7 muscle groups of those treated with SWISSOATS A111®. Furthermore, it was found that the exercise-induced rise in blood pressure was less severe in the treated group than in the placebo group. Remarkably, it was also recorded that diastolic pressure in SWISSOATS A111® group became lower. The anaerobic power as well as endurance time increased significantly after SWISSOATS A111® treatment, while the placebo group experienced virtually no change in these parameters. No side effects were noted.

Another study was done on benign senescent forgetfulness in which 75% showed favourable improvement in memory and mental alertness after taking SWISSOATS A111®.

A study conducted at the Hungarian University of Physical Education in Budapest measured the level of testosterone excretion following the use of SWISSOATS A111®. The subjects taking SWISSOATS A111® showed significantly higher testosterone excretion both in regard to pretreatment and compared to the placebo group.

Endocrine analyses from a crossover double-blind study on blood samples while the subjects were using SWISSOATS A111®. There was no increase in testosterone when the starting levels were already high, underscoring once more the safety of the product. It will return men to a healthy testosterone level, but not allow it to become excessive.

In Singapore, a study was done to determine the efficacy of SWISSOATS A111® in relieving andropause (male menopause) symptoms and improving total and free testosterone levels in Singapore men.

Seventy six adult males who consulted for symptoms of male menopause were recruited and given 300 mgs of SWISSOATS A111® preparation twice a day. Andropause score, total and free testosterone levels were determined prior to start of therapy and after 28 days of treatment. The results for each parameter were compared pre- and post therapy and subjected to statistical analysis using paired-T test to determine any significant difference.

The results showed that SWISSOATS A111®:

• Increased the free testosterone levels in patients with andropausal symptoms with or without impotence.
  
  
• Improved the andropause scores better than oral testosterone (Andriol) hormone replacement therapy and this is statistically significant (p<0.05).
  
  
• Works well with patients above 40 years and this effect is possibly due to its predominant androgenic effects (increase in free and total testosterone levels and improvement in andropause scores)
  
  
• Increase in libido or desire for sex may occur with increase in free testosterone levels and was the most frequent subjective and objective observation in the study.